Literature DB >> 16776459

Diabetes mellitus is strongly associated with tuberculosis in Indonesia.

B Alisjahbana1, R van Crevel, E Sahiratmadja, M den Heijer, A Maya, E Istriana, H Danusantoso, T H M Ottenhoff, R H H Nelwan, J W M van der Meer.   

Abstract

SETTING: Diabetes mellitus is a known risk factor for tuberculosis (TB), but no studies have been reported from South-East Asia, which has a high burden of TB and a rapidly growing prevalence of diabetes.
OBJECTIVE: To examine if and to what extent diabetes is associated with an increased risk of TB in an urban setting in Indonesia.
DESIGN: Case-control study comparing the prevalence of diabetes mellitus (fasting blood glucose level >126 mg/dl) among newly diagnosed pulmonary TB patients and matched neighbourhood controls.
RESULTS: Patients and control subjects had a similar age (median 30 years) and sex distribution (52% male), but malnutrition was more common among TB patients (median body mass index 17.7 vs. 21.5 kg/m2). HIV infection was uncommon (1.5% of patients). Diabetes mellitus was present in 60 of 454 TB patients (13.2%) and 18 of 556 (3.2%) control subjects (OR 4.7; 95%CI 2.7-8.1). Adjustment for possible confounding factors did not reduce the risk estimates. Following anti-tuberculosis treatment, hyperglycaemia reverted in a minority (3.7%) of TB patients.
CONCLUSION: Diabetes mellitus is strongly associated with TB in young and non-obese subjects in an urban setting in Indonesia. This may have implications for TB control and patient care in this region.

Entities:  

Mesh:

Year:  2006        PMID: 16776459

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  61 in total

1.  Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances.

Authors:  Blanca I Restrepo
Journal:  Clin Infect Dis       Date:  2007-07-05       Impact factor: 9.079

Review 2.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

3.  Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea.

Authors:  Eun Hye Lee; Jung Mo Lee; Young Ae Kang; Ah Young Leem; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Song Yee Kim
Journal:  Lung       Date:  2017-02-09       Impact factor: 2.584

Review 4.  Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations.

Authors:  Emily Mendenhall; Brandon A Kohrt; Shane A Norris; David Ndetei; Dorairaj Prabhakaran
Journal:  Lancet       Date:  2017-03-04       Impact factor: 79.321

5.  Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.

Authors:  Edhyana Sahiratmadja; Bachti Alisjahbana; Tjitske de Boer; Iskandar Adnan; Anugrah Maya; Halim Danusantoso; Ronald H H Nelwan; Sangkot Marzuki; Jos W M van der Meer; Reinout van Crevel; Esther van de Vosse; Tom H M Ottenhoff
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

6.  SCALING UP NON-COMMUNICABLE DISEASE CONTROL: LESSONS TO BE LEARNT FROM THE INFECTIOUS DISEASE PARADIGM IN KENYA.

Authors:  A Njoroge; K E Munene
Journal:  East Afr Med J       Date:  2015-12

Review 7.  Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.

Authors:  Roger K Verbeeck; Gunar Günther; Dan Kibuule; Christian Hunter; Tim W Rennie
Journal:  Eur J Clin Pharmacol       Date:  2016-06-15       Impact factor: 2.953

8.  Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokines.

Authors:  Nathella Pavan Kumar; Dina Nair; V V Banurekha; Chandrakumar Dolla; Paul Kumaran; Rathinam Sridhar; Subash Babu
Journal:  Cytokine       Date:  2016-01-06       Impact factor: 3.861

9.  The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus.

Authors:  J E Stalenhoef; B Alisjahbana; E J Nelwan; J van der Ven-Jongekrijg; T H M Ottenhoff; J W M van der Meer; R H Nelwan; M G Netea; R van Crevel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-26       Impact factor: 3.267

10.  A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization.

Authors:  Fiona Young; Julia A Critchley; Lucy K Johnstone; Nigel C Unwin
Journal:  Global Health       Date:  2009-09-14       Impact factor: 4.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.